The Ottawa Hospital becomes the 500th customer for RayStation treatment planning system
The Ottawa Hospital has placed an order for RayStation, RaySearch’s innovative radiation therapy treatment planning system, becoming the 500th customer. Since the first sale in 2009, RaySearch has worked hard to ensure that RayStation remains the premier treatment planning system, covering the broadest range of treatment delivery machines and providing the most comprehensive functionality. The steadily growing user base is a testament to the confidence cancer centers have in the system.
RayStation’s capabilities have evolved continuously through regular releases. The latest version, RayStation 8A*, includes full planning capabilities for Accuray TomoTherapy® systems, improvements for proton and carbon ion therapy and further integration with RayCare®*, the next-generation oncology information system.
The system is appreciated worldwide for advanced functionality such as VMAT, deformable dose accumulation, atlas-based segmentation and Plan Explorer, a unique feature that makes it possible to generate a large number of treatment plans automatically. RayStation functionality will continue to advance at a steady pace to take patient outcomes and clinical efficiency even further.
Dr. Jason Pantarotto, head of the Radiation Medicine Program at The Ottawa Hospital, says: “RayStation will complement our existing technology quite nicely, leading to efficiencies in treatment planning across multiple platforms. With almost 5000 courses of radiation delivered over multiple sites, efficiency is a key component to our care delivery model.”
Johan Löf, CEO of RaySearch, says: “We are very happy that we are now bringing the benefits of RayStation to 500 customers worldwide. RayStation has proven itself to be the premier treatment planning system. We are looking forward to an exciting future as we take automation to new levels and deepen integration with RayCare, the next-generation oncology information system. This is truly just the beginning.”
About The Ottawa Hospital
The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.
RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
To learn more about RaySearch, go to: www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00